We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jul 20
The Covid-19 vaccine is currently under development and the agreement with the UK government is subject to clinical…
17 Jul 20
J&J is preparing to start human trials of its Covid-19 vaccine this month and is working to accelerate…
08 Jul 20
The funding will support the late-stage clinical development, including pivotal Phase 3 clinical trial to support licensure and…
07 Jul 20
CureVac has reached a loan agreement with EIB for the development and production of vaccine candidate against SARS-CoV-2
17 Jun 20
The investment is aimed at strengthening Sanofi’s capability to advance the research and production of new advanced vaccines
21 Apr 20
Multiple sclerosis is a chronic disease that occurs when the immune system abnormally attacks the parts of nerve…
13 Apr 20
Pfizer and BioNTech will jointly develop COVID-19 vaccine, initially in the US and Europe, and scale-up manufacturing capacity…
09 Apr 20
Novavax will incorporate its Matrix-M adjuvant with NVX-CoV2373 to enhance immune responses and stimulate increased levels of neutralising…
09 Mar 20
The company's internal discovery programme is focused on its patented transgenic mouse platform (Harbour Mice) for generating fully…
03 Mar 20
The acquisition of Forty Seven will strengthen Gilead’s immuno-oncology research and development portfolio with the addition of Forty…